New York, New York--(Newsfile Corp. - February 9, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Novo Nordisk (NYSE: NVO ...

JPMorgan lowered the firm’s price target on Novo Nordisk (NVO) to DKK 1,000 from DKK 1,050 and keeps an Overweight rating on the shares. Published first on TheFly – the ultimate source for ...

Novo Nordisk shares rose after the drugmaker reported strong sales growth for its blockbuster obesity and diabetes drugs and issued a forecast for full-year 2025 results that topped analysts ...

The film is supported by NFI, Oslo Film Fund, Viken Filmsenter, Fritt Ord, Nordisk Film & TV Fond, Impact Partners, the Bergesen Foundation, and the Fund for Sound and Image.

Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this. On rare occasions, our expert team of analysts issues a “Double Down” stock ...

Karnataka Chief Minister Siddaramaiah unveiled the logo of the 16th Bengaluru International Film Festival at Cauvery Residence. On this occasion, Deputy Chief Minister D.K. Shivakumar and other ...

Nothing is really being done to curb that.” Watch on Deadline Lee also noted that the film is “uniquely South African” and that “it’s told in one of the 11 official languages [Xhosa].

Less-than-stellar phase 3 results with Novo Nordisk's highly anticipated obesity therapy CagriSema have caused its shares to fall by over a fifth, wiping around $94 billion off its market cap.

Novo Nordisk has filed another Citizen's Petition with the FDA seeking to block compounding pharmacies in the US from making versions of one of its GLP-1 agonist drugs. The latest attempt focuses ...

Exit polls in 2020 predicted a hat-trick for AAP in Delhi with around 56 of 70 Assembly seats going to AAP. In 2015, AAP won 67 seats and in its debut election in 2013, the party won 28 seats out ...

Novo Nordisk remains confident in CagriSema’s potential despite underwhelming Phase III results so far. Image credit: Shutterstock/ Kittyfly. Novo Nordisk is planning a new Phase III trial for ...